Sen. Bob Casey Criticized for Investment Ties Amid Fentanyl Crisis
Both Casey and opponent McCormick are entangled in accusations over investments in a Chinese fentanyl manufacturer, intensifying the Pennsylvania Senate race.
- Casey's campaign attacked McCormick for investing in a Chinese fentanyl manufacturer while leading Bridgewater Associates.
- Casey himself owns stock in the same company through a mutual fund, sparking accusations of hypocrisy.
- McCormick accuses Casey of failing to address the fentanyl crisis and border security during his tenure.
- The issue has highlighted the broader opioid crisis, which remains a critical concern for Pennsylvania voters.
- Recent polls show Casey leading McCormick, though the race remains highly contentious.